TapewireFind a company

person · Reporting owner

LIDDY EDWARD M

Disclosed activity across 5 companies

Tapewire entity
11626
SEC CIK
0001188983

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
3M COMMM · Entity 1275DirectorMay 01, 2020May 04, 2020
ABBOTT LABORATORIESABT · Entity 2314DirectorApril 24, 2020April 28, 2020
AbbVie Inc.ABBV · Entity 2800DirectorMarch 31, 2022April 04, 2022
BOEING COBA · Entity 2862DirectorApril 01, 2020April 03, 2020
GOLDMAN SACHS GROUP INCGS · Entity 2819DirectorDecember 19, 2007December 21, 2007

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

3M CO

Report date May 01, 2020 · Filed May 04, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectBy Corporation59,810.252 Reported balance After 2020-05-01 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2020-05-01 · Grant · Acquired 222.157 · Balance 59,810.252

F1: This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account.

F2: Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors.

Filing footnotes · ownership attribution and instrument terms

F1: This non-employee director has elected to defer all or a portion of compensation otherwise payable in cash or stock to a common stock equivalents account under the terms of 3M's Compensation Plan for Non-employee Directors and has no voting or investment powers with respect to such account.

F2: Includes acquisition of deferred dividend reinvestment shares pursuant to 3M's Compensation Plan for Non-Employee Directors.

ABBOTT LABORATORIES

Report date April 24, 2020 · Filed April 28, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common shares without par valueSEC Table I · non-derivativeDirect30,127 Reported balance After 2020-04-24 transaction · row 1
1 source row

Row 1 · 2020-04-24 · Grant · Acquired 1,974 · Balance 30,127

F1: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $93.68 · Expires 2030-04-23Direct9,671 Reported balance After 2020-04-24 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2020-04-24 · Grant · Acquired 9,671 · Balance 9,671

F2: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Filing footnotes · ownership attribution and instrument terms

F1: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F2: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

AbbVie Inc.

Report date March 31, 2022 · Filed April 04, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $162.11Direct28,474 Reported balance After 2022-03-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2022-03-31 · Grant · Acquired 177 · Balance 28,474

F1: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Filing footnotes · ownership attribution and instrument terms

F1: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

BOEING CO

Report date April 01, 2020 · Filed April 03, 2020

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00Direct22,925.88 Reported balance After 2020-04-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2020-04-01 · Grant · Acquired 108.14 · Balance 22,925.88

F1: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4: Includes adjustments for dividends accrued.

Filing footnotes · ownership attribution and instrument terms

F1: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4: Includes adjustments for dividends accrued.

GOLDMAN SACHS GROUP INC

Report date December 19, 2007 · Filed December 21, 2007

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect18,244 Reported balance After 2007-12-19 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2007-12-19 · Grant · Acquired 3,310 · Balance 18,244

F1: These Restricted Stock Units will convert into shares of the Issuer's Common Stock on the last business day in May in the year following the year of the retirement of the Reporting Person from the Issuer's Board of Directors.

Filing footnotes · ownership attribution and instrument terms

F1: These Restricted Stock Units will convert into shares of the Issuer's Common Stock on the last business day in May in the year following the year of the retirement of the Reporting Person from the Issuer's Board of Directors.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2014 Filed Jul 2, 2014 21:04 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 806 $40.90 Strike: $0.00 $32,965.40
Disclosure

SEC source: 0001179110-14-011301 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,504

Underlying: Common shares · 806 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2014 Filed Jul 2, 2014 17:16 UTC AbbVie Inc. ABBV · Entity 2800 GrantStock Equivalent Units · Derivative 611 $56.44 Strike: $0.00 $34,484.84
Disclosure

SEC source: 0001179110-14-011338 · edgar.xml · derivative · entry 6

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,681

Underlying: Common stock · 611 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature.

Read SEC document
May 09, 2014 Filed May 13, 2014 17:21 UTC AbbVie Inc. ABBV · Entity 2800 GrantCommon stock, $0.01 par value 2,764 $0.00 $0.00
Disclosure

SEC source: 0001179110-14-008318 · edgar.xml · nonDerivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,420

F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 25, 2014 Filed Apr 29, 2014 21:16 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 3,535 $0.00 $0.00
Disclosure

SEC source: 0001179110-14-007333 · edgar.xml · nonDerivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,753

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 01, 2014 Filed Apr 3, 2014 20:30 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 569.59 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-14-010003 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,147.95

Underlying: Common Stock · 569.59 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
March 31, 2014 Filed Apr 2, 2014 21:03 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 856 $38.51 Strike: $0.00 $32,964.56
Disclosure

SEC source: 0001179110-14-006272 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,638

Underlying: Common shares · 856 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
March 31, 2014 Filed Jul 2, 2014 17:16 UTC AbbVie Inc. ABBV · Entity 2800 GrantStock Equivalent Units · Derivative 671 $51.40 Strike: $0.00 $34,489.40
Disclosure

SEC source: 0001179110-14-011338 · edgar.xml · derivative · entry 5

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,990

Underlying: Common stock · 671 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature.

Read SEC document
January 02, 2014 Filed Jan 6, 2014 21:39 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 531.6 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-14-001002 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,502.02

Underlying: Common Stock · 531.6 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
December 31, 2013 Filed Jan 3, 2014 22:02 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 860 $38.33 Strike: $0.00 $32,963.80
Disclosure

SEC source: 0001179110-14-000232 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,726

Underlying: Common shares · 860 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
December 31, 2013 Filed Jul 2, 2014 17:16 UTC AbbVie Inc. ABBV · Entity 2800 GrantStock Equivalent Units · Derivative 653 $52.81 Strike: $0.00 $34,484.93
Disclosure

SEC source: 0001179110-14-011338 · edgar.xml · derivative · entry 4

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,246

Underlying: Common stock · 653 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature.

Read SEC document
October 01, 2013 Filed Oct 3, 2013 20:32 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 616.03 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-13-021517 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,923.95

Underlying: Common Stock · 616.03 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
September 30, 2013 Filed Oct 2, 2013 21:14 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 994 $33.19 Strike: $0.00 $32,990.86
Disclosure

SEC source: 0001179110-13-014988 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,832

Underlying: Common shares · 994 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2013 Filed Jul 2, 2014 17:16 UTC AbbVie Inc. ABBV · Entity 2800 GrantStock Equivalent Units · Derivative 771 $44.73 Strike: $0.00 $34,486.83
Disclosure

SEC source: 0001179110-14-011338 · edgar.xml · derivative · entry 3

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,522

Underlying: Common stock · 771 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature.

Read SEC document
July 01, 2013 Filed Jul 3, 2013 20:43 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 700.65 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-13-015797 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,251.99

Underlying: Common Stock · 700.65 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
June 30, 2013 Filed Jul 2, 2013 21:56 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 946 $34.88 Strike: $0.00 $32,996.48
Disclosure

SEC source: 0001179110-13-011336 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,807

Underlying: Common shares · 946 shares

Expires not disclosed

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2013 Filed Jul 2, 2014 17:16 UTC AbbVie Inc. ABBV · Entity 2800 GrantStock Equivalent Units · Derivative 834 $41.34 Strike: $0.00 $34,477.56
Disclosure

SEC source: 0001179110-14-011338 · edgar.xml · derivative · entry 2

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,680

Underlying: Common stock · 834 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature.

Read SEC document
May 06, 2013 Filed May 8, 2013 17:10 UTC AbbVie Inc. ABBV · Entity 2800 GrantCommon stock, $0.01 par value 2,535 $0.00 $0.00
Disclosure

SEC source: 0001179110-13-008010 · edgar.xml · nonDerivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,656

F1 · kind: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the AbbVie 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 26, 2013 Filed Apr 30, 2013 21:16 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 3,097 $0.00 $0.00
Disclosure

SEC source: 0001179110-13-007415 · edgar.xml · nonDerivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,218

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 01, 2013 Filed Apr 3, 2013 20:35 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 846.86 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-13-009491 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,496.31

Underlying: Common Stock · 846.86 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
March 31, 2013 Filed Apr 1, 2013 21:27 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 934 $35.32 Strike: $0.00 $32,988.88
Disclosure

SEC source: 0001179110-13-006093 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,835

Underlying: Common shares · 934 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
March 31, 2013 Filed Jul 2, 2014 17:16 UTC AbbVie Inc. ABBV · Entity 2800 GrantStock Equivalent Units · Derivative 846 $40.78 Strike: $0.00 $34,499.88
Disclosure

SEC source: 0001179110-14-011338 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,786

Underlying: Common stock · 846 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.exercise_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F1 · derivative.expiration_date: Director fees credited to stock equivalent unit accounts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend equivalent reinvestment feature.

Read SEC document
January 02, 2013 Filed Jan 4, 2013 22:04 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 942.91 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-13-000870 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,586.23

Underlying: Common Stock · 942.91 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
December 31, 2012 Filed Jan 3, 2013 22:14 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 503 $65.50 Strike: $0.00 $32,946.50
Disclosure

SEC source: 0001179110-13-000229 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,878

Underlying: Common shares · 503 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
October 01, 2012 Filed Oct 3, 2012 20:43 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 943.26 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-12-020855 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,586.42

Underlying: Common Stock · 943.26 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
September 30, 2012 Filed Oct 2, 2012 21:04 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 481 $68.56 Strike: $0.00 $32,977.36
Disclosure

SEC source: 0001179110-12-014772 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,331

Underlying: Common shares · 481 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
July 02, 2012 Filed Jul 5, 2012 20:08 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 900.2 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-12-015936 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,591.23

Underlying: Common Stock · 900.2 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
June 30, 2012 Filed Jul 3, 2012 21:18 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 511 $64.47 Strike: $0.00 $32,944.17
Disclosure

SEC source: 0001179110-12-011155 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,813

Underlying: Common shares · 511 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
April 27, 2012 Filed May 1, 2012 21:09 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 1,819 $0.00 $0.00
Disclosure

SEC source: 0001179110-12-007451 · edgar.xml · nonDerivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,121

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 02, 2012 Filed Apr 4, 2012 21:08 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 888.78 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-12-009391 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,641.59

Underlying: Common Stock · 888.78 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
March 31, 2012 Filed Apr 3, 2012 21:02 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 538 $61.29 Strike: $0.00 $32,974.02
Disclosure

SEC source: 0001179110-12-006273 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,265

Underlying: Common shares · 538 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
January 03, 2012 Filed Jan 5, 2012 21:54 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 888.55 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-12-000878 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,713.4

Underlying: Common Stock · 888.55 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
December 31, 2011 Filed Jan 4, 2012 22:10 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 586 $56.23 Strike: $0.00 $32,950.78
Disclosure

SEC source: 0001179110-12-000242 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,695

Underlying: Common shares · 586 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
October 03, 2011 Filed Oct 5, 2011 20:20 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 1,109.9 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-11-023027 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,790.81

Underlying: Common Stock · 1,109.9 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
September 30, 2011 Filed Oct 4, 2011 21:04 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 645 $51.14 Strike: $0.00 $32,985.30
Disclosure

SEC source: 0001179110-11-013925 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,081

Underlying: Common shares · 645 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
July 01, 2011 Filed Jul 6, 2011 16:32 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 892.08 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-11-017625 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,650.59

Underlying: Common Stock · 892.08 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
June 30, 2011 Filed Jul 1, 2011 21:06 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 608 $52.62 Strike: $0.00 $31,992.96
Disclosure

SEC source: 0001179110-11-010395 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,413

Underlying: Common shares · 608 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
April 29, 2011 Filed May 3, 2011 21:21 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 2,167 $0.00 $0.00
Disclosure

SEC source: 0001179110-11-007230 · edgar.xml · nonDerivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,302

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 01, 2011 Filed Apr 5, 2011 20:32 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 840.11 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-11-011227 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,737.46

Underlying: Common Stock · 840.11 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Pursuant to The Deferred Compensation Plan for Directors of The Boeing Company, phantom stock units are distributed as shares of common stock after the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
March 31, 2011 Filed Apr 1, 2011 21:08 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 611 $49.05 Strike: $0.00 $29,969.55
Disclosure

SEC source: 0001179110-11-005775 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,788

Underlying: Common shares · 611 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
January 03, 2011 Filed Jan 4, 2011 22:29 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 942.12 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-11-000720 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,880.33

Underlying: Common Stock · 942.12 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
December 31, 2010 Filed Jan 4, 2011 22:05 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 615 $47.91 Strike: $0.00 $29,464.65
Disclosure

SEC source: 0001179110-11-000351 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,166

Underlying: Common shares · 615 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
October 01, 2010 Filed Oct 5, 2010 21:12 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 854.07 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-10-022283 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,926.01

Underlying: Common Stock · 854.07 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
September 30, 2010 Filed Oct 1, 2010 22:24 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 545 $52.24 Strike: $0.00 $28,470.80
Disclosure

SEC source: 0001179110-10-014516 · edgar.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 545

Underlying: Common shares · 545 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
July 01, 2010 Filed Jul 6, 2010 18:59 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 1,065.03 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-10-016698 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,065.03

Underlying: Common Stock · 1,065.03 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

Read SEC document
October 01, 2008 Filed Oct 3, 2008 22:29 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 904.12 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001225208-08-015853 · doc4.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,590.24

Underlying: Common Stock · 904.12 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
July 01, 2008 Filed Jul 3, 2008 17:20 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 783.76 $0.00 $0.00
Disclosure

SEC source: 0001137638-08-000070 · lid1888.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,669.09

Underlying: Common · 783.76 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
April 01, 2008 Filed Apr 3, 2008 21:43 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 680.2 $0.00 $0.00
Disclosure

SEC source: 0001137638-08-000052 · lid1853.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875.3

Underlying: Common · 680.2 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
January 02, 2008 Filed Jan 4, 2008 19:06 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 589.62 $0.00 $0.00
Disclosure

SEC source: 0001137638-08-000008 · lid1793.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,188.98

Underlying: Common · 589.62 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document
December 19, 2007 Filed Dec 21, 2007 17:07 UTC GOLDMAN SACHS GROUP INC GS · Entity 2819 GrantRestricted Stock Units · Derivative 3,310 Not disclosed Not disclosed
Disclosure

SEC source: 0000769993-07-001147 · liddyeep_ex.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,244

Underlying: Common Stock · 3,310 shares

Expires not disclosed

F1 · derivative.exercise_price: These Restricted Stock Units will convert into shares of the Issuer's Common Stock on the last business day in May in the year following the year of the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · price: These Restricted Stock Units will convert into shares of the Issuer's Common Stock on the last business day in May in the year following the year of the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.exercise_date: These Restricted Stock Units will convert into shares of the Issuer's Common Stock on the last business day in May in the year following the year of the retirement of the Reporting Person from the Issuer's Board of Directors.

F1 · derivative.expiration_date: These Restricted Stock Units will convert into shares of the Issuer's Common Stock on the last business day in May in the year following the year of the retirement of the Reporting Person from the Issuer's Board of Directors.

Read SEC document
October 01, 2007 Filed Oct 3, 2007 21:50 UTC BOEING CO BA · Entity 2862 GrantPhantom Stock Units · Derivative 597.11 $0.00 $0.00
Disclosure

SEC source: 0001137638-07-000169 · lid1773.xml · derivative · entry 1

LIDDY EDWARD M · CIK 0001188983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 597.11

Underlying: Common · 597.11 shares

Expires not disclosed

F1 · derivative.exercise_price: Phantom stock units are convertible into common stock on a 1-for-1 basis.

F2 · shares: Phantom stock units awarded or acquired in lieu of director cash compensation.

F3 · derivative.exercise_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F3 · derivative.expiration_date: Phantom stock units accrued under The Boeing Company's Deferred Compensation Plan for Directors are to be settled in The Boeing Company common stock upon the reporting person's termination of services as a director.

F4 · balance_after: Includes adjustments for dividends accrued.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.